Literature DB >> 17691312

Brain stimulation for epilepsy.

W H Theodore1, R Fisher.   

Abstract

Brain stimulation has been receiving increasing attention as an alternative therapy for epilepsy that cannot be treated by either antiepileptic medication or surgical resection of the epileptogenic focus. The stimulation methods include transcranial magnetic stimulation (TMS) or electrical stimulation by implanted devices of the vagus nerve (VNS), deep brain structures (DBS) (thalamic or hippocampal), cerebellar or cortical areas. TMS is the simplest and least invasive approach. However, the most common epileptogenic areas (mesial temporal structures) probably lie too deep beneath the surface of the skull for effective TMS. The efficacy of VNS in reducing the frequency or severity of seizures is quite variable and depends on many factors which are currently investigated. VNS is well-tolerated and approved in many countries. DBS is much more invasive than either TMS or VNS. Currently, a number of targets for DBS are investigated including caudate, centromedian or anterior thalamic nuclei, and subthalamic nucleus. Direct stimulation of the epileptic cortical focus is another approach to the neuromodulation in epilepsy. Finally, another line of research investigates the usefulness of implantable seizure detection devices. The current chapter presents the most important evidence on the above methods. Furthermore, other important issues are reviewed such as the selection criteria of patients for brain stimulation and the potential role of brain stimulation in the treatment of depression in epileptic patients.

Entities:  

Mesh:

Year:  2007        PMID: 17691312     DOI: 10.1007/978-3-211-33081-4_29

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  21 in total

1.  Hippocampal deep brain stimulation reduces glucose utilization in the healthy rat brain.

Authors:  Nathalie Van Den Berge; Vincent Keereman; Christian Vanhove; Bregt Van Nieuwenhuyse; Pieter van Mierlo; Robrecht Raedt; Kristl Vonck; Paul Boon; Roel Van Holen
Journal:  Mol Imaging Biol       Date:  2015-06       Impact factor: 3.488

2.  The sound of noninvasive seizure control.

Authors:  Detlev Boison
Journal:  Epilepsy Curr       Date:  2011-11       Impact factor: 7.500

Review 3.  Commentary: physical approaches for the treatment of epilepsy: electrical and magnetic stimulation and cooling.

Authors:  Wolfgang Löscher; Andrew J Cole; Michael J McLean
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

4.  Outcomes remain ambivalent for deep brain stimulation and epilepsy.

Authors:  Elinor Ben-Menachem
Journal:  Epilepsy Curr       Date:  2008 Sep-Oct       Impact factor: 7.500

5.  Temperatures achieved in human and canine neocortex during intraoperative passive or active focal cooling.

Authors:  Matthew D Smyth; Rowland H Han; Chester K Yarbrough; Edward E Patterson; Xiao-Feng Yang; John W Miller; Steven M Rothman; Raimondo D'Ambrosio
Journal:  Ther Hypothermia Temp Manag       Date:  2015-04-22       Impact factor: 1.286

6.  Electrical stimulation therapies for CNS disorders and pain are mediated by competition between different neuronal networks in the brain.

Authors:  Carl L Faingold
Journal:  Med Hypotheses       Date:  2008-08-30       Impact factor: 1.538

Review 7.  An open hypothesis: is epilepsy learned, and can it be unlearned?

Authors:  David Hsu; Wei Chen; Murielle Hsu; John M Beggs
Journal:  Epilepsy Behav       Date:  2008-06-24       Impact factor: 2.937

Review 8.  Deep brain stimulation for psychiatric disorders.

Authors:  Jens Kuhn; Theo O J Gründler; Doris Lenartz; Volker Sturm; Joachim Klosterkötter; Wolfgang Huff
Journal:  Dtsch Arztebl Int       Date:  2010-02-19       Impact factor: 5.594

9.  Epilepsy: The future scenario.

Authors:  H V Srinivas
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

10.  Towards a non-invasive interictal application of hypothermia for treating seizures: a feasibility and pilot study.

Authors:  A Bagić; W H Theodore; E A Boudreau; R Bonwetsch; J Greenfield; W Elkins; S Sato
Journal:  Acta Neurol Scand       Date:  2008-03-18       Impact factor: 3.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.